Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms

Authors
Publication date
1 January 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio della Ricerca - Università di Salerno

    redirect
    oaioai:www.iris.unisa.it:11386/47...
    Last time updated on 23/08/2022